XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
Accounting for Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-based Compensation Expense

The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in millions):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Effect on income before income taxes

 

$

(5

)

 

$

(8

)

Effect on net loss

 

$

(4

)

 

$

(6

)

Schedule of Share-based Payment Awards, Stock Options, Valuation Assumptions

The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three months ended March 31, 2022 and 2021:

 

 

 

Three Months Ended

March 31,

 

 

 

2022

 

 

2021

 

Expected volatility

 

84.3% - 87.5%

 

 

84.3% - 88.9%

 

Expected dividends

 

 

 

 

 

 

Expected term

 

3 - 6 years

 

 

3 - 6 years

 

Risk-free interest rate

 

1.5% - 1.6%

 

 

0.3% - 0.9%

 

Schedule of Share-based Compensation, Stock Options, Activity

Options outstanding and exercisable under the 2009 Plan as of March 31, 2022, and changes during the three-month period following December 31, 2021, was as follows (in millions, except share and per share data):

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Average

 

Intrinsic

 

 

 

 

 

 

 

Average

 

 

Remaining

 

Value as of

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

March 31,

 

 

 

Shares

 

 

Price

 

 

Term

 

2022

 

Outstanding at December 31, 2021

 

 

2,301,753

 

 

$

6.77

 

 

 

 

 

 

 

Granted

 

 

760,000

 

 

 

10.18

 

 

 

 

 

 

 

Exercised

 

 

(56,500

)

 

 

4.97

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(151,002

)

 

 

14.67

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

2,854,251

 

 

$

7.30

 

 

8.5 years

 

$

13

 

Exercisable at March 31, 2022

 

 

1,316,912

 

 

$

5.64

 

 

7.7 years

 

$

8

 

Schedule of Share-based Compensation, Restricted Stock, Activity

Restricted stock outstanding under the 2009 Plan as of March 31, 2022, and changes during the three-month period following December 31, 2021, was as follows:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2021

 

 

4,995,314

 

 

$

6.30

 

Granted

 

 

3,179,000

 

 

 

9.05

 

Vested

 

 

(2,516,247

)

 

 

5.62

 

Forfeited

 

 

(30,000

)

 

 

6.87

 

Unvested at March 31, 2022

 

 

5,628,067

 

 

 

8.61

 

Schedule of Share-based Compensation, Restricted Stock Units, Activity

RSUs outstanding under the 2009 Plan as of March 31, 2022, and changes during the three-month period following December 31, 2021, was as follows:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2021

 

 

486,598

 

 

$

6.17

 

Granted

 

 

159,138

 

 

 

10.18

 

Vested

 

 

(151,058

)

 

 

5.63

 

Forfeited

 

 

 

 

 

 

Unvested at March 31, 2022

 

 

494,678

 

 

 

7.63